Last reviewed · How we verify

NCT03748004

IPS/Peer Support Intervention in the DTES

Status unknown NA Last updated 17 June 2019
What this trial tests

NA trial testing IPS/SP in Behavior, Adaptive in 72 participants. Status unknown.

Timeline
14 November 2018
Primary endpoint
30 November 2019
1 May 2020

Quick facts

Lead sponsorUniversity of British Columbia
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment72
Start date14 November 2018
Primary completion30 November 2019
Estimated completion1 May 2020
Sites3 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of British Columbia

Who can join

19 and older, any sex, with Behavior, Adaptive or Mental Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Individual placement support (IPS) is an evidence-based supported employment model for people with severe mental illness, designed to achieve employment in mainstream competitive jobs, either part-time or full-time. The aim of this study is to assess the (i) effectiveness of embedding the (IPS)/Peer Support intervention as part of the primary care centre in securing employment of adults living in the downtown eastside in comparison to the usual treatment WorkBC (control group). (ii) effectiveness of IPS/Peer Support versus the usual treatment (WorkBC) in improving mental illness, quality of life and personal recovery through participation in employment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of British Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03748004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing